Natural history of cerebral vein thrombosis

Current Opinion in Pulmonary Medicine

Volumn 13, Issue 5, 2007, Pages 372-376

  Dentali, Francesco ^a   Ageno, Walter ^a,b  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b OSPEDALE DI CIRCOLO   (Italy)

Author keywords

Cerebral vein thrombosis; Natural history

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; PLACEBO;

ANTICOAGULANT THERAPY; BRAIN HEMORRHAGE; BRAIN VEIN; CEREBRAL VEIN THROMBOSIS; CLINICAL TRIAL; COGNITIVE DEFECT; CONVALESCENCE; DISABILITY; DRUG EFFICACY; FOLLOW UP; HUMAN; INCIDENCE; MINIMAL RESIDUAL DISEASE; MORTALITY; PREDICTOR VARIABLE; PROGNOSIS; RECANALIZATION; RECURRENT DISEASE; REVIEW; SEIZURE; SURVIVAL; THROMBOEMBOLISM; TREATMENT OUTCOME; VEIN THROMBOSIS;

DISABILITY EVALUATION; DISEASE PROGRESSION; HUMANS; INTRACRANIAL THROMBOSIS; PROGNOSIS; RECURRENCE; VENOUS THROMBOSIS;

EID: 34748897829     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e3282058b81     Document Type: Review

References (26)

1. Ameri A, Bousser MG. Cerebral venous thrombosis. Neurol Clin 1992; 10:87-111.
2. Gates PC. Cerebral venous thrombosis. A retrospective review. Aust N Z J Med 1986; 16:766-770.
3. Dentali F, Crowther M, Ageno W. Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: a meta-analysis. Blood 2006; 107:2766-2773. This is a first meta-analysis on risk factors for CVT.
4. Einhaupl KM, Villringer A, Meister W, et al. Heparin treatment in sinus venous thrombosis. Lancet 1991; 338:597-600.
5. de Bruijn SF, Stam J. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke 1999; 30:484-488.
6. Ferro JM, Canhao P, Stam J, et al., ISCVT Investigators. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 2004; 35: 664-670.
7. Gosk-Bierska I, Wysokinski W, Brown RD Jr, et al. Cerebral venous sinus thrombosis: Incidence of venous thrombosis recurrence and survival. Neurology 2006; 67:814-819. This describes a large study with a long follow-up on the natural history of cerebral vein thrombosis.
8. de Bruijn SF, de Haan RJ, Stam J. Clinical features and prognostic factors of cerebral venous sinus thrombosis in a prospective series of 59 patients. For The Cerebral Venous Sinus Thrombosis Study Group. J Neurol Neurosurg Psychiatry 2001; 70:105-108.
9. Stolz E, Rahimi A, Gerriets T, et al. Cerebral venous thrombosis: an all or nothing disease? Prognostic factors and long-term outcome. Clin Neurol Neurosurg 2005; 107:99-107.
10. Buccino G, Scoditti U, Patteri I, et al. Neurological and cognitive long-term outcome in patients with cerebral venous sinus thrombosis. Acta Neurol Scand 2003; 107:330-335.
11. Cakmak S, Derex L, Berruyer M, et al. Cerebral venous thrombosis: clinical outcome and systematic screening of prothrombotic factors. Neurology 2003; 60:1175-1178.
12. Ferro JM, Lopes MG, Rosas MJ, et al. Cerebral Venous Thrombosis Portuguese Collaborative Study Group. Long-term prognosis of cerebral vein and dural sinus thrombosis. Results of the VENOPORT study. Cerebrovasc Dis 2002; 13:272-278.
13. Breteau G, Mounier-Vehier F, Godefroy O, et al. Cerebral venous thrombosis 3-year clinical outcome in 55 consecutive patients. J Neurol 2000; 250: 29-35.
14. Preter M, Tzourio C, Ameri A, Bousser MG. Long-term prognosis in cerebral venous thrombosis. Follow-up of 77 patients. Stroke 1996; 27:243-246.
15. Appenzeller S, Zeller CB, Annichino-Bizzachi JM, et al. Cerebral venous thrombosis: influence of risk factors and imaging findings on prognosis. Clin Neurol Neurosurg 2005; 107:371-378.
16. Dentali F, Gianni M, Crowther MA, Ageno W. Natural history of cerebral vein thrombosis: a systematic review. Blood 2006; 108:1129-1134. This is the first systematic review on the natural history of cerebral vein thrombosis.
17. van Den Belt AG, Prins MH, Lensing AW, et al. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. Cochrane Database Syst Rev 2000; (2): CD001100.
18. Stolz E, Trittmacher S, Rahimi A, et al. Influence of recanalization on outcome in dural sinus thrombosis: a prospective study. Stroke 2004; 35:544-547.
19. Favrole P, Guichard JP, Crassard I, et al. Diffusion-weighted imaging of intravascular clots in cerebral venous thrombosis. Stroke 2004; 35:99-103.
20. Baumgartner RW, Studer A, Arnold M, Georgiadis D. Recanalisation of cerebral venous thrombosis. J Neurol Neurosurg Psychiatry 2003; 74: 459-461.
21. Strupp M, Covi M, Seelos K, et al. Cerebral venous thrombosis: correlation between recanalization and clinical outcome: a long-term follow-up of 40 patients. J Neurol 2002; 249:1123-1124.
22. Mehraein S, Ortwein H, Busch M, et al. Risk of recurrence of cerebral venous and sinus thrombosis during subsequent pregnancy and puerperium. J Neurol Neurosurg Psychiatry 2003; 74:814-816.
23. Lamy C, Hamon JB, Coste J, Mas JL. Ischemic stroke in young women: risk of recurrence during subsequent pregnancies. French Study Group on Stroke in Pregnancy. Neurology 2000; 55:269-274.
24. Girot M, Ferro JM, Canhao P, et al. ISCVT Investigators. Predictors of outcome in patients with cerebral venous thrombosis and intracerebral hemorrhage. Stroke 2007; 38:337-342.
25. Masuhr F, Busch M, Amberger N, et al. Risk and predictors of early epileptic seizures in acute cerebral venous and sinus thrombosis. Eur J Neurol 2006; 13:852-856.
26. Canhao P, Ferro JM, Lindgren AG, et al. ISCVT Investigators. Causes and predictors of death in cerebral venous thrombosis. Stroke 2005; 36:1720-1725.